RARA CRAFT DATABASE for FDA Medical Devices
PMAP160017S076

FDA DEVICE FACTS

MiniMed 770G System

Medtronic Minimed, Inc.

Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。

DECISION DATEAugust 31, 2020PRODUCT CODEOZP

Indications for use

MiniMed 770G System The MiniMed 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 770G System includes SmartGuard technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring

(CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed 770G System consists of the following devices: MiniMed 770G Insulin Pump, the Guardian Link (3) Transmitter, the Guardian Sensor (3), one-press serter, the Accu-Chek Guide™ Link blood glucose meter, and the Accu-Chek Guide™ Test Strips. The system requires a prescription.

The Guardian Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian Sensor (3).

Guardian Sensor (3) The Guardian Sensor (3) is intended for use with the MiniMed 770G system, MiniMed 670G system, MiniMed 630G system, and Guardian Connect system to continuously monitor glucose levels in persons with diabetes.

The sensor is intended for single use and requires a prescription. The Guardian Sensor (3) is indicated for seven days of continuous use.

The Guardian Sensor (3) has been studied and is approved for use in the systems, insertion sites, and ages listed in the following table:

System Approved Age Sensor Insertion Site MiniMed 770G System 2-13 14 and older Abdomen and Buttocks Abdomen and Arm MiniMed 670G System 7-13 14 and older Abdomen and Buttocks Abdomen and Arm MiniMed 630G System 14 and older Abdomen and Arm Guardian Connect System 14 and older Abdomen and Arm

One-press Serter The serter is used as an aid for inserting the sensor. It is indicated for single-patient use and it is not intended for multiple-patient use.

Guardian Link (3) Transmitter The Guardian Link (3) Transmitter is intended for use with the MiniMed 770G System. The Guardian Link (3) Transmitter powers the glucose sensor, collects and calculates sensor data, and wirelessly sends the data to the MiniMed 770G insulin pump. The Transmitter is intended for single-patient multi-use.

Accu-Chek Guide™ Link Blood Glucose Monitoring System The Accu-Chek Guide™ Link Blood Glucose Monitoring System is comprised of the Accu- Chek Guide™ Link meter and the Accu-Chek Guide™ test strips.

The Accu-Chek Guide™ Link Blood Glucose Monitoring System is intended to quantitatively measure glucose in fresh capillary whole blood from the fingertip, palm, and upper arm as an aid in monitoring the effectiveness of glucose control.

The Accu-Chek Guide™ Link Blood Glucose Monitoring System is intended for in vitro diagnostic single-patient use by people with diabetes.

The Accu-Chek Guide™ Link Blood Glucose Monitoring System is intended to be used by a single person and should not be shared.

This system is not for use in diagnosing or screening for diabetes mellitus and not for neonatal use.

Alternative site testing should be done only during steady-state times (when glucose is not changing rapidly).

The Accu-Chek Guide™ Link Blood Glucose Monitoring System is intended to be used to wirelessly transmit glucose values to the MiniMed 770G system with Bluetooth wireless technology through the use of Bluetooth low energy communication.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 2, 2026